The Novo Nordisk Foundation awarded DKK 4.2 billion in grants for scientific, humanitarian and social purposes in 2016. The amount awarded is the highest ever by the Foundation in a single year. The grants were awarded for many projects that can potentially improve people’s health and welfare.
“Our ambition is to increase grant funding further in 2017. We will support research, education and innovation, especially within the medical sciences and biotechnology. We will also give higher priority to grants for humanitarian and social purposes,” says Sten Scheibye, Chairman of the Foundation’s Board.
The Foundation supports research that targets developing new knowledge on why diseases occur and how they can be prevented and treated. The Foundation also supports research focusing on developing new technology and other scientific purposes.
Birgitte Nauntofte, CEO of the Novo Nordisk Foundation, says: “In 2016, the Foundation awarded DKK 848 million for research projects in open competition. We support talented researchers at all stages of their careers and both small and large projects of high quality. In 2016, we added new research programmes in such fields as basic medical research, general practice and nursing, and we plan to continue to expand the number of programmes offered in the coming years.”
The Novo Nordisk Foundation is also supporting the treatment of people with diabetes in Denmark. In 2016, the Foundation awarded nearly DKK 3 billion to the Capital Region of Denmark to establish Steno Diabetes Center Copenhagen. The Foundation is currently discussing with Denmark’s other regions about strengthening diabetes initiatives intended to ensure uniform high-quality treatment for everyone with diabetes in Denmark, regardless of where they live.
Since 2010, the Foundation has donated more than DKK 10 billion (€1.3 billion) to benefit society.
Christian Mostrup Scheel, Press Officer, phone: 3067 4805, email@example.com